Association between blood lead and walking speed in the national health and nutrition examination survey (NHANES 1999-2002)

Environmental Health Perspectives

Volumn 121, Issue 6, 2013, Pages 711-716

  Ji, John S ^a   Elbaz, Alexis ^b,c   Weisskopf, Marc G ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Environmental epidemiology; Gait speed; Lead; NHANES; Toxicant; Walking speed

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEINE; LEAD;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD PRESSURE MEASUREMENT; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; INFLAMMATION; LEAD POISONING; LIFESTYLE; LINEAR REGRESSION ANALYSIS; MALE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; TISSUE INJURY; WAIST CIRCUMFERENCE; WALKING SPEED;

AGED; AGED, 80 AND OVER; CEREBELLUM; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LEAD; MALE; MIDDLE AGED; NUTRITION SURVEYS; TIME FACTORS; WALKING;

EID: 84878462978     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1205918     Document Type: Article

References (76)

1. Abellan van Kan G, Rolland Y, Andrieu S, Bauer J, Beauchet O, Bonnefoy M, et al. 2009. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging 13(10):881-889.
2. Agency for Toxic Substances and Disease Registry. 2007. Toxicological Profile for Lead. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
3. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, et al. 1993. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 25(1):71-80.
4. Albert CM, Ma J, Rifai N, Stampfer MJ, Ridker PM. 2002. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105(22):2595-2599.
5. Atkinson HH, Rosano C, Simonsick EM, Williamson JD, Davis C, Ambrosius WT, et al. 2007. Cognitive function, gait speed decline, and comorbidities: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 62(8):844-850.
6. Baezner H, Blahak C, Poggesi A, Pantoni L, Inzitari D, Chabriat H, et al. 2008. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 70(12):935-942.
7. Baker EL Jr, Landrigan PJ, Barbour AG, Cox DH, Folland DS, Ligo RN, et al. 1979. Occupational lead poisoning in the United States: clinical and biochemical findings related to blood lead levels. Br J Ind Med 36(4):314-322.
8. Bandeen-Roche K, Glass TA, Bolla KI, Todd AC, Schwartz BS. 2009. Cumulative lead dose and cognitive function in older adults. Epidemiology 20(6):831-839.
9. Bleecker ML, Ford DP, Celio MA, Vaughan CG, Lindgren KN. 2007. Impact of cognitive reserve on the relationship of lead exposure and neurobehavioral performance. Neurology 69(5):470-476.
10. Bohannon RW. 1997. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing 26(1):15-19.
11. Bohannon RW. 2008. Population representative gait speed and its determinants. J Geriatr Phys Ther 31(2):49-52.
12. Boyer KA, Kiratli BJ, Andriacchi TP, Beaupre GS. 2011. Maintaining femoral bone density in adults: how many steps per day are enough? Osteoporos Int 22(12):2981-2988.
13. Brunner EJ, Shipley MJ, Witte DR, Singh-Manoux A, Britton AR, Tabak AG, et al. 2011. Arterial stiffness, physical function, and functional limitation: the Whitehall II Study. Hypertension 57(5):1003-1009.
14. Buchman AS, Boyle PA, Leurgans SE, Evans DA, Bennett DA. 2009. Pulmonary function, muscle strength, and incident mobility disability in elders. Proc Am Thorac Soc 6(7):581-587.
15. Bunn TL, Marsh JA, Dietert RR. 2000. Gender differences in developmental immunotoxicity to lead in the chicken: analysis following a single early low-level exposure in ovo. J Toxicol Environ Health A 61(8):677-693.
16. Bunn TL, Parsons PJ, Kao E, Dietert RR. 2001. Gender-based profiles of developmental immunotoxicity to lead in the rat: assessment in juveniles and adults. J Toxicol Environ Health A 64(3):223-240.
17. Centers for Disease Control and Prevention. 2009. National Health and Nutrition Examination Survey (NHANES) Laboratory Procedures Manual. Available: http://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/lab.pdf [accessed 2 May 2013].
18. Centers for Disease Control and Prevention. 2012. National Health and Nutrition Examination Survey. Available: http:// www.cdc.gov/nchs/nhanes.htm [accessed 28 November 2012].
19. Cocchini G, Della Sala S, Logie RH, Pagani R, Sacco L, Spinnler H. 2004. Dual task effects of walking when talking in Alzheimer's disease. Rev Neurol (Paris) 160(1):74-80.
20. Coon S, Stark A, Peterson E, Gloi A, Kortsha G, Pounds J, et al. 2006. Whole-body lifetime occupational lead exposure and risk of Parkinson's disease. Environ Health Perspect 114:1872-1876.
21. Cooper R, Hardy R, Aihie Sayer A, Ben-Shlomo Y, Birnie K, Cooper C, et al. 2011. Age and gender differences in physical capability levels from mid-life onwards: the harmonisation and meta-analysis of data from eight UK cohort studies. PLoS One 6(11):e27899; doi:10.1371/journal. pone.0027899 [Online 16 November 2011].
22. Dumurgier J, Elbaz A, Ducimetiere P, Tavernier B, Alperovitch A, Tzourio C. 2009. Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ 339:b4460; doi: http://dx.doi.org/10.1136/bmj. b4460 [Online 10 November 2009].
23. Dumurgier J, Elbaz A, Dufouil C, Tavernier B, Tzourio C. 2010. Hypertension and lower walking speed in the elderly: the Three-City study. J Hypertens 28(7):1506-1514.
24. Elbaz A, Ripert M, Tavernier B, Fevrier B, Zureik M, Gariepy J, et al. 2005. Common carotid artery intima-media thickness, carotid plaques, and walking speed. Stroke 36(10):2198-2202.
25. Evans GW, Kantrowitz E. 2002. Socioeconomic status and health: the potential role of environmental risk exposure. Annu Rev Public Health 23:303-331.
26. Fitzpatrick AL, Buchanan CK, Nahin RL, Dekosky ST, Atkinson HH, Carlson MC, et al. 2007. Associations of gait speed and other measures of physical function with cognition in a healthy cohort of elderly persons. J Gerontol A Biol Sci Med Sci 62(11):1244-1251.
27. Goldberg M, Chastang JF, Leclerc A, Zins M, Bonenfant S, Bugel I, et al. 2001. Socioeconomic, demographic, occupational, and health factors associated with participation in a long-term epidemiologic survey: a prospective study of the French GAZEL cohort and its target population. Am J Epidemiol 154(4):373-384.
28. Graham JE, Ostir GV, Fisher SR, Ottenbacher KJ. 2008. Assessing walking speed in clinical research: a systematic review. J Eval Clin Pract 14(4):552-562.
29. Grashow R, Spiro A, Taylor KM, Newton K, Shrairman R, Landau A, et al. 2013. Cumulative lead exposure in community-dwelling adults and fine motor function: comparing standard and novel tasks in the VA Normative Aging Study. Neurotoxicology 35C:154-161.
30. Hajjar I, Yang F, Sorond F, Jones RN, Milberg W, Cupples LA, et al. 2009. A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms: relationship to blood pressure and other cardiovascular risks. J Gerontol A Biol Sci Med Sci 64(9):994-1001.
31. Hall WJ. 2006. Update in geriatrics. Ann Intern Med 145(7):538-543.
32. Hausdorff JM, Yogev G, Springer S, Simon ES, Giladi N. 2005. Walking is more like catching than tapping: gait in the elderly as a complex cognitive task. Exp Brain Res 164(4):541-548.
33. Hu H, Rabinowitz M, Smith D. 1998. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 106:1-8.
34. Inzitari M, Baldereschi M, Di Carlo A, Di Bari M, Marchionni N, Scafato E, et al. 2007. Impaired attention predicts motor performance decline in older community-dwellers with normal baseline mobility: results from the Italian Longitudinal Study on Aging (ILSA). J Gerontol A Biol Sci Med Sci 62(8):837-843.
35. Ko SU, Stenholm S, Chia CW, Simonsick EM, Ferrucci L. 2011. Gait pattern alterations in older adults associated with type 2 diabetes in the absence of peripheral neuropathy- results from the Baltimore Longitudinal Study of Aging. Gait Posture 34(4):548-552.
36. Kuo HK, Bean JF, Yen CJ, Leveille SG. 2006a. Linking C-reactive protein to late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. J Gerontol A Biol Sci Med Sci 61(4):380-387.
37. Kuo HK, Leveille SG, Yen CJ, Chai HM, Chang CH, Yeh YC, et al. 2006b. Exploring how peak leg power and usual gait speed are linked to late-life disability: data from the National Health and Nutrition Examination Survey (NHANES), 1999-2002. Am J Phys Med Rehabil 85(8):650-658.
38. Kuo HK, Leveille SG, Yu YH, Milberg WP. 2007a. Cognitive function, habitual gait speed, and late-life disability in the National Health and Nutrition Examination Survey (NHANES) 1999-2002. Gerontology 53(2):102-110.
39. Kuo HK, Liao KC, Leveille SG, Bean JF, Yen CJ, Chen JH, et al. 2007b. Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults. J Gerontol A Biol Sci Med Sci 62(4):434-439.
40. Kwon J, Suzuki T, Yoshida H, Kim H, Yoshida Y, Iwasa H, et al. 2007. Association between change in bone mineral density and decline in usual walking speed in elderly communitydwelling Japanese women during 2 years of follow-up. J Am Geriatr Soc 55(2):240-244.
41. Lang IA, Scarlett A, Guralnik JM, Depledge MH, Melzer D, Galloway TS. 2009. Age-related impairments of mobility associated with cobalt and other heavy metals: data from NHANES 1999-2004. J Toxicol Environ Health A 72(6):402-409.
42. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. 2005. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 113:894-899.
43. Launer LJ, Wind AW, Deeg DJ. 1994. Nonresponse pattern and bias in a community-based cross-sectional study of cognitive functioning among the elderly. Am J Epidemiol 139(8):803-812.
44. Lindsey C, Brownbill RA, Bohannon RA, Ilich JZ. 2005. Association of physical performance measures with bone mineral density in postmenopausal women. Arch Phys Med Rehabil 86(6):1102-1107.
45. McConnell P, Berry M. 1979. The effects of postnatal lead exposure on Purkinje cell dendritic development in the rat. Neuropathol Appl Neurobiol 5(2):115-132.
46. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. 2006. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults. Circulation 114(13):1388-1394.
47. Miller DT, Paschal DC, Gunter EW, Stroud PE, D'Angelo J. 1987. Determination of lead in blood using electrothermal atomisation atomic absorption spectrometry with a L'vov platform and matrix modifier. Analyst 112(12):1701-1704.
48. Morton SM, Bastian AJ. 2003. Relative contributions of balance and voluntary leg-coordination deficits to cerebellar gait ataxia. J Neurophysiol 89(4):1844-1856.
49. Nash D, Magder L, Lustberg M, Sherwin RW, Rubin RJ, Kaufmann RB, et al. 2003. Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal women. JAMA 289(12):1523-1532.
50. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. 2007. Lead exposure and cardiovascular disease-a systematic review. Environ Health Perspect 115:472-482.
51. Navas-Acien A, Silbergeld EK, Sharrett R, Calderon-Aranda E, Selvin E, Guallar E. 2005. Metals in urine and peripheral arterial disease. Environ Health Perspect 113:164-169.
52. Ostir GV, Volpato S, Fried LP, Chaves P, Guralnik JM. 2002. Reliability and sensitivity to change assessed for a summary measure of lower body function: results from the Women's Health and Aging Study. J Clin Epidemiol 55(9):916-921.
53. Palombaro KM, Hack LM, Mangione KK, Barr AE, Newton RA, Magri F, et al. 2009. Gait variability detects women in early postmenopause with low bone mineral density. Phys Ther 89(12):1315-1326.
54. Parsons PJ, Slavin W. 1993. A rapid Zeeman graphite furnace atomic absorption spectrometric method for the determination of lead in blood. Spectrochim Acta Part B At Spectrosc (6/7):925-939.
55. Patrick GW, Anderson WJ. 2000. Dendritic alterations of cerebellar Purkinje neurons in postnatally lead-exposed kittens. Dev Neurosci 22(4):320-328.
56. Ris MD, Dietrich KN, Succop PA, Berger OG, Bornschein RL. 2004. Early exposure to lead and neuropsychological outcome in adolescence. J Int Neuropsychol Soc 10(2):261-270.
57. Rosano C, Aizenstein HJ, Studenski S, Newman AB. 2007. A regions-of-interest volumetric analysis of mobility limitations in community-dwelling older adults. J Gerontol A Biol Sci Med Sci 62(9):1048-1055.
58. Rosano C, Simonsick EM, Harris TB, Kritchevsky SB, Brach J, Visser M, et al. 2005. Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology 24(1-2):8-14.
59. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM. 2006. Blood lead levels and death from all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. Environ Health Perspect 114:1538-1541.
60. Sheridan PL, Solomont J, Kowall N, Hausdorff JM. 2003. Influence of executive function on locomotor function: divided attention increases gait variability in Alzheimer's disease. J Am Geriatr Soc 51(11):1633-1637.
61. Shih RA, Glass TA, Bandeen-Roche K, Carlson MC, Bolla KI, Todd AC, et al. 2006. Environmental lead exposure and cognitive function in community-dwelling older adults. Neurology 67(9):1556-1562.
62. Shih RA, Hu H, Weisskopf MG, Schwartz BS. 2007. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 115:483-492.
63. Soumare A, Elbaz A, Zhu Y, Maillard P, Crivello F, Tavernier B, et al. 2009a. White matter lesions volume and motor performances in the elderly. Ann Neurol 65(6):706-715.
64. Soumare A, Tavernier B, Alperovitch A, Tzourio C, Elbaz A. 2009b. A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people. J Gerontol A Biol Sci Med Sci 64(10):1058-1065.
65. Strandhagen E, Berg C, Lissner L, Nunez L, Rosengren A, Toren K, et al. 2010. Selection bias in a population survey with regis try linkage: potential effect on socioeconomic gradient in cardiovascular risk. Eur J Epidemiol 25(3):163-172.
66. Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, et al. 2011. Gait speed and survival in older adults. JAMA 305(1):50-58.
67. Taaffe DR, Simonsick EM, Visser M, Volpato S, Nevitt MC, Cauley JA, et al. 2003. Lower extremity physical performance and hip bone mineral density in elderly black and white men and women: cross-sectional associations in the Health ABC Study. J Gerontol A Biol Sci Med Sci 58(10):M934-M942.
68. Tsaih SW, Korrick S, Schwartz J, Amarasiriwardena C, Aro A, Sparrow D, et al. 2004. Lead, diabetes, hypertension, and renal function: the normative aging study. Environ Health Perspect 112:1178-1182.
69. Vahter M, Åkesson A, Liden C, Ceccatelli S, Berglund M. 2007. Gender differences in the disposition and toxicity of metals. Environ Res 104(1):85-95.
70. Wechsler D, ed. 1997. WAIS-III WMS-III Technical Manual. San Antonio, TX: Psychological Corporation.
71. Weisskopf MG, Hu H, Mulkern RV, White R, Aro A, Oliveira S, et al. 2004. Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning. Environ Health Perspect 112:620-625.
72. Weisskopf MG, Jain N, Nie H, Sparrow D, Vokonas P, Schwartz J, et al. 2009. A prospective study of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in the Department of Veterans Affairs Normative Aging Study. Circulation 120(12):1056-1064.
73. Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A III, Sparrow D, et al. 2007. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology 18(1):59-66.
74. Weisskopf MG, Weuve J, Nie H, Saint-Hilaire MH, Sudarsky L, Simon DK, et al. 2010. Association of cumulative lead exposure with Parkinson's disease. Environ Health Perspect 118:1609-1613.
75. Weuve J, Korrick SA, Weisskopf MG, Ryan LM, Schwartz J, Nie H, et al. 2009. Cumulative exposure to lead in relation to cognitive function in older women. Environ Health Perspect 117:574-580.
76. Yeh JH, Chang YC, Wang JD. 1995. Combined electroneurographic and electromyographic studies in lead workers. Occup Environ Med 52(6):415-419.